Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-09-05 00:00:00 ET · period of report 2025-09-05 · accession 0000950170-25-113311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-09-05 | 2025-09-05 | AXSM | Saad Mark E | Dir | S - Sale+OE | $125.07 | -9,127 | 10.0K | -48% | -$1.14M |
| DT | 2025-09-05 | 2025-09-05 | AXSM | Saad Mark E | Dir | M - OptEx | $9.00 | +9,127 | 19.1K | +91% | +$82.1K |
| DT | 2025-09-05 | 2025-09-05 | AXSM | Saad Mark E | Dir | M - OptEx | $0.00 | -9,127 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | S | D | 9,127 | $125.07 | 10,002 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $125.00 and $125.22. |
| 2 | Common | Common Stock | 2025-09-05 | M | A | 9,127 | $9.00 | 19,129 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-09-05 | M | D | 9,127 | $0.00 | 0 | D | $9.00 · 2016-11-19 to 2025-11-19 | 9,127 Common Stock |